Stock UniverseDerived research view · source repositories remain read-only

IQVIA Holdings Inc. (IQV)

Life Science Tools / Diagnostics / MedTech · Healthcare / Diagnostics & Research
Score Band
High
Selection Score
43.06
Global Rank
175
Market Cap
30.34B
Latest Close
183.45
RS Composite
-10.74% · G#2139

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
3.96%
3M
5.13%
6M
-19.27%
1Y
24.04%
3Y
-6.84%
5Y
-23.61%
10Y
170.22%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 965.82K · 30-day average: 1.78M · Max drawdown over stored range: -51.52%

Research Snapshot

Relative Strength vs SPX

RS Composite-10.74%
20D RS2.06%
60D RS-2.05%
120D RS-25.82%
Global RS Rank2139 · 36.24% percentile
Qualified+ RS Rank800 · 36.41% percentile
Group ScopeQualified+
Primary RS Rank76 · 46.48% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank14 / 246
Primary Percentile94.72
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-0516.63B1.62B2.20B1.39B8.074.28B1.02B3.26B172M9.72%13.23%8.33%25.75%19.60%2.10B13.99B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$8.0722.7x$96.921.9x$19.009.7x$24.967.3x

Shares Diluted: 172M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1387414410149841540516310
Revenue Growth (YoY)22.141%3.863%3.983%2.81%5.875%
Gross Profit46415028523953755430
Operating Income14461860207122792298
Free Cash Flow23021586150021142051
Free Cash Flow Per Share11.8058.3218.05211.52711.821
EPS (Diluted) GAAP4.955.727.297.497.84
EPS Growth246.154%15.556%27.448%2.743%4.673%
EPS Non-GAAP
Gross Margin33.451%34.892%34.964%34.891%33.292%
Operating Margin10.422%12.908%13.821%14.794%14.09%
Profit Margin6.963%7.571%9.063%8.913%8.338%
Free Cash Flow Margin16.592%11.006%10.011%13.723%12.575%
Shares Outstanding (Diluted)195190.6186.3183.4173.5
Shares Change (YoY)7900%-2.256%-2.256%-1.557%-5.398%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-054.15B9.18%514.00M12.38%274.00M6.60%1.61169.80M2.10B13.99Bprocessed
2025 Q42026-02-174.36B10.91%627.00M14.37%514.00M11.78%2.99171.70M2.14B13.88Bprocessed
2025 Q32025-10-284.10B9.02%553.00M13.49%331.00M8.07%1.93171.70M1.97B12.79Bprocessed
2025 Q22025-07-224.02B9.68%506.00M12.60%266.00M6.62%1.54173.20M2.19B14.18Bprocessed
2025 Q12025-05-063.83B9.40%496.00M12.95%249.00M6.50%1.40177.40M1.88B13.11Bprocessed
2024 Q42025-02-133.96B-27.36%626.00M15.82%437.00M11.04%2.42180.70M1.84B12.84Bprocessed
2024 Q32024-10-313.90B23.49%550.00M14.12%285.00M7.32%1.55184.20M1.71B12.29Bprocessed
2024 Q22024-07-223.81B22.63%520.00M13.63%363.00M9.52%1.97184.30M1.68B12.09Bprocessed
2024 Q12024-05-023.74B22.13%506.00M13.54%288.00M7.71%1.56184.30M1.57B12.82Bprocessed
2023 Q42024-02-153.87B-26.47%501.00M12.95%469.00M12.13%2.54184.50M1.50B12.96Bprocessed
2023 Q32023-11-013.74B23.07%481.00M12.87%303.00M8.11%1.63185.50M1.33B12.32Bprocessed
2023 Q22023-08-013.73B22.80%524.00M14.06%297.00M7.97%1.59186.70M1.49B12.43Bprocessed
2023 Q12023-04-283.65B21.96%471.00M12.90%289.00M7.91%1.53188.60M1.60B11.83Bprocessed
2022 Q42023-02-153.74B-22.89%379.00M10.14%227.00M6.07%1.20188.50M1.31B12.60Bprocessed
2022 Q32022-10-273.56B22.80%472.00M13.25%283.00M7.94%1.49189.40M1.36B12.24Bprocessed
2022 Q22022-07-223.54B22.45%453.00M12.79%256.00M7.23%1.34191.10M1.52B12.62Bprocessed
2022 Q12022-04-283.57B22.39%495.00M13.87%325.00M9.11%1.68193.40M1.49B12.55Bprocessed
2021 Q42022-02-163.64B-19.66%463.00M12.73%318.00M8.75%1.63195.00M1.48B12.03Bprocessed
2021 Q32021-10-223.39B21.44%302.00M8.91%261.00M7.70%1.34195.30M1.57B12.08Bprocessed
2021 Q22021-07-283.44B20.80%286.00M8.32%175.00M5.09%0.90194.90M1.91B12.14Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.